NEXGEL, Inc. (NXGL) 10-Year Financial Performance & Capital Metrics

NXGL • • Industrial / General

HealthcareMedical InstrumentsWound Care & Therapeutic DevicesAdvanced Wound Care

AboutNEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.Show more

Revenue $9M +112.5%
EBITDA -$3M -1.3%
Net Income -$3M -3.9%
EPS (Diluted) -0.50 +10.7%
Gross Margin 31.63% +245.8%
EBITDA Margin -35.38% +52.3%
Operating Margin -40.91% +51.9%
Net Margin -37.76% +51.1%
ROE -58.35% -18.3%
ROIC -43.12% -14.8%
Debt/Equity 0.46 -14.2%
Interest Coverage -43.88 +81.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 64.7%

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 10 (bottom 10%)
✗Shares diluted 14.8% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y64.69%

3Y77.6%

TTM73.38%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM18.39%

EPS CAGR

10Y-

5Y-

3Y-

TTM34.48%

ROCE

10Y Avg-150.18%

5Y Avg-74.54%

3Y Avg-38.06%

Latest-44.65%

Peer Comparison

Advanced Wound Care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
NEPHNephros, Inc.	46.54M	4.38	625.71	-0.53%	8.26%	14.8%	0.16
NXGLNEXGEL, Inc.	14.17M	1.74	-3.48	112.47%	-24.69%	-51.65%	0.46
SMTISanara MedTech Inc.	212.4M	23.77	-20.85	33.36%	-36.79%	-6.11%	0.83

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	2.15M	1.99M	2.21M	717K	674K	1.55M	2.05M	4.09M	8.69M
Revenue Growth %	-	-0.07%	0.11%	-0.68%	-0.06%	1.3%	0.32%	1%	1.12%
Cost of Goods Sold+	2.27M	1.84M	1.7M	854K	965K	1.54M	1.79M	3.71M	5.94M
COGS % of Revenue	1.05%	0.93%	0.77%	1.19%	1.43%	0.99%	0.88%	0.91%	0.68%
Gross Profit+	-114K	147K	514K	-137K	-291K	8K	256K	374K	2.75M
Gross Margin %	-0.05%	0.07%	0.23%	-0.19%	-0.43%	0.01%	0.13%	0.09%	0.32%
Gross Profit Growth %	-	2.29%	2.5%	-1.27%	-1.12%	1.03%	31%	0.46%	6.35%
Operating Expenses+	1.75M	1.12M	2.4M	1.79M	1.97M	2.58M	3.6M	3.85M	6.3M
OpEx % of Revenue	0.81%	0.56%	1.09%	2.49%	2.92%	1.66%	1.76%	0.94%	0.73%
Selling, General & Admin	1.75M	1.12M	2.4M	0	1.97M	2.4M	2.82M	3.4M	5.91M
SG&A % of Revenue	0.81%	0.56%	1.09%	-	2.92%	1.55%	1.38%	0.83%	0.68%
Research & Development	0	0	0	0	0	31K	367K	103K	78K
R&D % of Revenue	-	-	-	-	-	0.02%	0.18%	0.03%	0.01%
Other Operating Expenses	0	0	0	1.79M	0	142K	421K	350K	313K
Operating Income+	-1.86M	-969K	-1.89M	-1.92M	-2.26M	-2.57M	-3.35M	-3.48M	-3.55M
Operating Margin %	-0.87%	-0.49%	-0.85%	-2.68%	-3.35%	-1.66%	-1.63%	-0.85%	-0.41%
Operating Income Growth %	-	0.48%	-0.95%	-0.02%	-0.17%	-0.14%	-0.3%	-0.04%	-0.02%
EBITDA+	-1.54M	-653K	-1.57M	-1.86M	-2.21M	-2.43M	-3.05M	-3.03M	-3.07M
EBITDA Margin %	-0.72%	-0.33%	-0.71%	-2.59%	-3.28%	-1.57%	-1.49%	-0.74%	-0.35%
EBITDA Growth %	-	0.58%	-1.4%	-0.19%	-0.19%	-0.1%	-0.25%	0%	-0.01%
D&A (Non-Cash Add-back)	324K	316K	322K	67K	50K	138K	301K	443K	480K
EBIT	-1.86M	-969K	-1.89M	-1.92M	-2.25M	-2.31M	-3.41M	-3.17M	-3.38M
Net Interest Income+	0	0	0	0	-10K	-2M	-1.34M	-15K	-81K
Interest Income	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	10K	2M	1.34M	15K	81K
Other Income/Expense	25K	0	0	1K	-4K	-1.74M	-1.4M	289K	91K
Pretax Income+	-1.84M	-969K	-1.89M	-1.92M	-2.26M	-4.31M	-4.75M	-3.19M	-3.46M
Pretax Margin %	-0.85%	-0.49%	-0.85%	-2.68%	-3.36%	-2.78%	-2.32%	-0.78%	-0.4%
Income Tax+	-63K	-16K	0	0	0	0	0	0	0
Effective Tax Rate %	0.97%	0.98%	1%	1%	1%	1%	1%	0.99%	0.95%
Net Income+	-1.78M	-953K	-1.89M	-1.92M	-2.26M	-4.31M	-4.75M	-3.16M	-3.28M
Net Margin %	-0.83%	-0.48%	-0.85%	-2.68%	-3.36%	-2.78%	-2.32%	-0.77%	-0.38%
Net Income Growth %	-	0.46%	-0.98%	-0.02%	-0.18%	-0.9%	-0.1%	0.33%	-0.04%
Net Income (Continuing)	-1.78M	-953K	-1.89M	-1.92M	-2.26M	-4.31M	-4.75M	-3.19M	-3.46M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	469K	325K
EPS (Diluted)+	-0.32	-0.17	-0.34	-0.35	-0.41	-0.77	-0.85	-0.56	-0.50
EPS Growth %	-	0.47%	-1%	-0.03%	-0.17%	-0.88%	-0.1%	0.34%	0.11%
EPS (Basic)	-0.32	-0.17	-0.34	-0.35	-0.41	-0.77	-0.85	-0.56	-0.50
Diluted Shares Outstanding	5.57M	5.57M	5.57M	5.57M	5.57M	5.57M	5.57M	5.67M	6.51M
Basic Shares Outstanding	5.57M	5.57M	5.57M	5.57M	5.57M	5.57M	5.57M	5.67M	6.51M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	257K	199K	361K	513K	363K	13.93M	7.5M	5.05M	5.11M
Cash & Short-Term Investments	0	0	0	261K	32K	13.35M	6.61M	2.7M	1.81M
Cash Only	0	0	0	261K	32K	13.35M	1.1M	2.7M	1.81M
Short-Term Investments	0	0	0	0	0	0	5.51M	0	0
Accounts Receivable	74K	99K	34K	102K	73K	209K	222K	633K	933K
Days Sales Outstanding	12.55	18.14	5.61	51.92	39.53	49.18	39.57	56.5	39.2
Inventory	158K	93K	101K	113K	233K	291K	502K	1.32M	1.75M
Days Inventory Outstanding	25.45	18.4	21.7	48.3	88.13	68.84	102.25	129.59	107.6
Other Current Assets	0	0	0	0	0	0	109K	336K	577K
Total Non-Current Assets+	1M	695K	378K	1.38M	1.89M	3.06M	2.85M	4.9M	5.87M
Property, Plant & Equipment	831K	522K	200K	1.2M	1.36M	2.65M	2.46M	3.35M	3.84M
Fixed Asset Turnover	2.59x	3.82x	11.07x	0.60x	0.50x	0.59x	0.83x	1.22x	2.26x
Goodwill	0	0	0	0	311K	311K	311K	1.13M	1.13M
Intangible Assets	0	0	0	0	47K	33K	20K	326K	807K
Long-Term Investments	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	173K	173K	178K	178K	178K	63K	63K	95K	95K
Total Assets+	1.26M	894K	739K	1.89M	2.26M	16.98M	10.36M	9.96M	10.98M
Asset Turnover	1.71x	2.23x	2.99x	0.38x	0.30x	0.09x	0.20x	0.41x	0.79x
Asset Growth %	-	-0.29%	-0.17%	1.56%	0.19%	6.52%	-0.39%	-0.04%	0.1%
Total Current Liabilities+	384K	210K	407K	800K	1.33M	2.89M	859K	2.55M	2.47M
Accounts Payable	147K	63K	157K	510K	658K	254K	265K	1.23M	1.29M
Days Payables Outstanding	23.68	12.46	33.73	217.97	248.88	60.08	53.98	121.14	79.39
Short-Term Debt	0	0	0	0	216K	2.05M	15K	325K	97K
Deferred Revenue (Current)	0	0	0	0	38K	54K	0	20K	179K
Other Current Liabilities	66K	27K	142K	69K	170K	272K	316K	677K	606K
Current Ratio	0.67x	0.95x	0.89x	0.64x	0.27x	4.82x	8.74x	1.98x	2.07x
Quick Ratio	0.26x	0.50x	0.64x	0.50x	0.10x	4.72x	8.15x	1.46x	1.36x
Cash Conversion Cycle	14.32	24.07	-6.42	-117.75	-121.22	57.94	87.84	64.95	67.4
Total Non-Current Liabilities+	83K	59K	51K	710K	854K	2.01M	1.86M	2.24M	2.43M
Long-Term Debt	0	0	0	0	256K	266K	268K	513K	588K
Capital Lease Obligations	0	0	0	710K	598K	1.74M	1.59M	1.73M	1.84M
Deferred Tax Liabilities	16K	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	83K	59K	51K	0	0	0	0	0	0
Total Liabilities	467K	269K	458K	1.51M	2.19M	4.9M	2.72M	4.79M	4.9M
Total Debt+	0	0	0	917K	1.28M	4.26M	2.08M	2.8M	2.83M
Net Debt	0	0	0	656K	1.25M	-9.09M	982K	98K	1.02M
Debt / Equity	-	-	-	2.41x	17.99x	0.35x	0.27x	0.54x	0.46x
Debt / EBITDA	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-
Interest Coverage	-	-	-	-	-226.00x	-1.29x	-2.51x	-231.80x	-43.88x
Total Equity+	794K	625K	281K	380K	71K	12.09M	7.64M	5.17M	6.08M
Equity Growth %	-	-0.21%	-0.55%	0.35%	-0.81%	169.21%	-0.37%	-0.32%	0.18%
Book Value per Share	0.14	0.11	0.05	0.07	0.01	2.17	1.37	0.91	0.93
Total Shareholders' Equity	794K	625K	281K	380K	71K	12.09M	7.64M	4.7M	5.75M
Common Stock	794K	625K	281K	57K	99K	6K	6K	6K	8K
Retained Earnings	0	0	0	-238K	-2.5M	-6.81M	-11.56M	-14.71M	-18M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	469K	325K

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.32M	-777K	-1.54M	-1.81M	-1.8M	-2.75M	-2.99M	-3.24M	-3.87M
Operating CF Margin %	-0.61%	-0.39%	-0.7%	-2.53%	-2.67%	-1.77%	-1.46%	-0.79%	-0.45%
Operating CF Growth %	-	0.41%	-0.99%	-0.17%	0.01%	-0.53%	-0.09%	-0.08%	-0.19%
Net Income	-1.78M	-953K	-1.89M	-1.92M	-2.26M	-4.31M	-4.75M	-3.16M	-3.28M
Depreciation & Amortization	324K	316K	322K	67K	50K	113K	301K	443K	478K
Stock-Based Compensation	12K	7K	206K	4K	232K	285K	298K	217K	367K
Deferred Taxes	-63K	-16K	0	0	2K	-225K	0	0	0
Other Non-Cash Items	-9K	-8K	-14K	-1K	2K	1.98M	1.39M	-318K	-260K
Working Capital Changes	195K	-123K	36K	39K	177K	-593K	-234K	-421K	-1.17M
Change in Receivables	212K	-27K	66K	-68K	29K	-137K	-13K	-411K	-300K
Change in Inventory	46K	60K	-3K	-12K	-99K	-58K	-211K	-760K	-432K
Change in Payables	-35K	-84K	94K	203K	137K	-405K	11K	968K	182K
Cash from Investing+	0	-7K	0	0	-312K	-269K	-5.59M	4.46M	-775K
Capital Expenditures	0	-7K	0	0	-312K	-269K	-96K	-696K	-443K
CapEx % of Revenue	-	0%	-	-	0.46%	0.17%	0.05%	0.17%	0.05%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	-96K	-500K	0
Cash from Financing+	1.32M	784K	1.54M	2.08M	1.88M	16.34M	-3.66M	379K	3.75M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	1.32M	784K	1.54M	1.34M	0	-115K	0	0	-241K
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-1.32M	-784K	-1.54M	-1.81M	-2.11M	-3.02M	-3.09M	-3.93M	-4.31M
FCF Margin %	-0.61%	-0.39%	-0.7%	-2.53%	-3.14%	-1.95%	-1.51%	-0.96%	-0.5%
FCF Growth %	-	0.4%	-0.97%	-0.17%	-0.16%	-0.43%	-0.02%	-0.27%	-0.1%
FCF per Share	-0.24	-0.14	-0.28	-0.33	-0.38	-0.54	-0.55	-0.69	-0.66
FCF Conversion (FCF/Net Income)	0.74x	0.82x	0.82x	0.94x	0.80x	0.64x	0.63x	1.03x	1.18x
Interest Paid	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-223.68%	-134.32%	-416.78%	-581.85%	-1003.99%	-70.91%	-48.13%	-49.32%	-58.35%
Return on Invested Capital (ROIC)	-176.07%	-102.43%	-312.58%	-219.13%	-144.13%	-89.34%	-43.23%	-37.57%	-43.12%
Gross Margin	-5.3%	7.38%	23.23%	-19.11%	-43.18%	0.52%	12.5%	9.15%	31.63%
Net Margin	-82.53%	-47.84%	-85.31%	-268.2%	-335.9%	-277.89%	-231.74%	-77.21%	-37.76%
Debt / Equity	-	-	-	2.41x	17.99x	0.35x	0.27x	0.54x	0.46x
Interest Coverage	-	-	-	-	-226.00x	-1.29x	-2.51x	-231.80x	-43.88x
FCF Conversion	0.74x	0.82x	0.82x	0.94x	0.80x	0.64x	0.63x	1.03x	1.18x
Revenue Growth	-	-7.43%	11.09%	-67.6%	-6%	130.12%	32.04%	99.66%	112.47%

Revenue by Segment

	2023	2024
Contract Manufacturing	1.98M	1.98M
Contract Manufacturing Growth	-	-0.05%
Other Incomes	76K	243K
Other Incomes Growth	-	219.74%

Frequently Asked Questions

Growth & Financials

NEXGEL, Inc. (NXGL) reported $11.7M in revenue for fiscal year 2024. This represents a 442% increase from $2.2M in 2016.

NEXGEL, Inc. (NXGL) grew revenue by 112.5% over the past year. This is strong growth.

NEXGEL, Inc. (NXGL) reported a net loss of $2.9M for fiscal year 2024.

Dividend & Returns

NEXGEL, Inc. (NXGL) has a return on equity (ROE) of -58.3%. Negative ROE indicates the company is unprofitable.

NEXGEL, Inc. (NXGL) had negative free cash flow of $2.5M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

NEXGEL, Inc. (NXGL) 10-Year Financial Performance & Capital Metrics

NXGL • • Industrial / General

HealthcareMedical InstrumentsWound Care & Therapeutic DevicesAdvanced Wound Care

Revenue $9M +112.5%
EBITDA -$3M -1.3%
Net Income -$3M -3.9%
EPS (Diluted) -0.50 +10.7%
Gross Margin 31.63% +245.8%
EBITDA Margin -35.38% +52.3%
Operating Margin -40.91% +51.9%
Net Margin -37.76% +51.1%
ROE -58.35% -18.3%
ROIC -43.12% -14.8%
Debt/Equity 0.46 -14.2%
Interest Coverage -43.88 +81.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 64.7%

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 10 (bottom 10%)
✗Shares diluted 14.8% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y64.69%

3Y77.6%

TTM73.38%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM18.39%

EPS CAGR

10Y-

5Y-

3Y-

TTM34.48%

ROCE

10Y Avg-150.18%

5Y Avg-74.54%

3Y Avg-38.06%

Latest-44.65%

Peer Comparison

Advanced Wound Care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
NEPHNephros, Inc.	46.54M	4.38	625.71	-0.53%	8.26%	14.8%	0.16
NXGLNEXGEL, Inc.	14.17M	1.74	-3.48	112.47%	-24.69%	-51.65%	0.46
SMTISanara MedTech Inc.	212.4M	23.77	-20.85	33.36%	-36.79%	-6.11%	0.83

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	2.15M	1.99M	2.21M	717K	674K	1.55M	2.05M	4.09M	8.69M
Revenue Growth %	-	-0.07%	0.11%	-0.68%	-0.06%	1.3%	0.32%	1%	1.12%
Cost of Goods Sold+	2.27M	1.84M	1.7M	854K	965K	1.54M	1.79M	3.71M	5.94M
COGS % of Revenue	1.05%	0.93%	0.77%	1.19%	1.43%	0.99%	0.88%	0.91%	0.68%
Gross Profit+	-114K	147K	514K	-137K	-291K	8K	256K	374K	2.75M
Gross Margin %	-0.05%	0.07%	0.23%	-0.19%	-0.43%	0.01%	0.13%	0.09%	0.32%
Gross Profit Growth %	-	2.29%	2.5%	-1.27%	-1.12%	1.03%	31%	0.46%	6.35%
Operating Expenses+	1.75M	1.12M	2.4M	1.79M	1.97M	2.58M	3.6M	3.85M	6.3M
OpEx % of Revenue	0.81%	0.56%	1.09%	2.49%	2.92%	1.66%	1.76%	0.94%	0.73%
Selling, General & Admin	1.75M	1.12M	2.4M	0	1.97M	2.4M	2.82M	3.4M	5.91M
SG&A % of Revenue	0.81%	0.56%	1.09%	-	2.92%	1.55%	1.38%	0.83%	0.68%
Research & Development	0	0	0	0	0	31K	367K	103K	78K
R&D % of Revenue	-	-	-	-	-	0.02%	0.18%	0.03%	0.01%
Other Operating Expenses	0	0	0	1.79M	0	142K	421K	350K	313K
Operating Income+	-1.86M	-969K	-1.89M	-1.92M	-2.26M	-2.57M	-3.35M	-3.48M	-3.55M
Operating Margin %	-0.87%	-0.49%	-0.85%	-2.68%	-3.35%	-1.66%	-1.63%	-0.85%	-0.41%
Operating Income Growth %	-	0.48%	-0.95%	-0.02%	-0.17%	-0.14%	-0.3%	-0.04%	-0.02%
EBITDA+	-1.54M	-653K	-1.57M	-1.86M	-2.21M	-2.43M	-3.05M	-3.03M	-3.07M
EBITDA Margin %	-0.72%	-0.33%	-0.71%	-2.59%	-3.28%	-1.57%	-1.49%	-0.74%	-0.35%
EBITDA Growth %	-	0.58%	-1.4%	-0.19%	-0.19%	-0.1%	-0.25%	0%	-0.01%
D&A (Non-Cash Add-back)	324K	316K	322K	67K	50K	138K	301K	443K	480K
EBIT	-1.86M	-969K	-1.89M	-1.92M	-2.25M	-2.31M	-3.41M	-3.17M	-3.38M
Net Interest Income+	0	0	0	0	-10K	-2M	-1.34M	-15K	-81K
Interest Income	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	10K	2M	1.34M	15K	81K
Other Income/Expense	25K	0	0	1K	-4K	-1.74M	-1.4M	289K	91K
Pretax Income+	-1.84M	-969K	-1.89M	-1.92M	-2.26M	-4.31M	-4.75M	-3.19M	-3.46M
Pretax Margin %	-0.85%	-0.49%	-0.85%	-2.68%	-3.36%	-2.78%	-2.32%	-0.78%	-0.4%
Income Tax+	-63K	-16K	0	0	0	0	0	0	0
Effective Tax Rate %	0.97%	0.98%	1%	1%	1%	1%	1%	0.99%	0.95%
Net Income+	-1.78M	-953K	-1.89M	-1.92M	-2.26M	-4.31M	-4.75M	-3.16M	-3.28M
Net Margin %	-0.83%	-0.48%	-0.85%	-2.68%	-3.36%	-2.78%	-2.32%	-0.77%	-0.38%
Net Income Growth %	-	0.46%	-0.98%	-0.02%	-0.18%	-0.9%	-0.1%	0.33%	-0.04%
Net Income (Continuing)	-1.78M	-953K	-1.89M	-1.92M	-2.26M	-4.31M	-4.75M	-3.19M	-3.46M
Discontinued Operations	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	469K	325K
EPS (Diluted)+	-0.32	-0.17	-0.34	-0.35	-0.41	-0.77	-0.85	-0.56	-0.50
EPS Growth %	-	0.47%	-1%	-0.03%	-0.17%	-0.88%	-0.1%	0.34%	0.11%
EPS (Basic)	-0.32	-0.17	-0.34	-0.35	-0.41	-0.77	-0.85	-0.56	-0.50
Diluted Shares Outstanding	5.57M	5.57M	5.57M	5.57M	5.57M	5.57M	5.57M	5.67M	6.51M
Basic Shares Outstanding	5.57M	5.57M	5.57M	5.57M	5.57M	5.57M	5.57M	5.67M	6.51M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	257K	199K	361K	513K	363K	13.93M	7.5M	5.05M	5.11M
Cash & Short-Term Investments	0	0	0	261K	32K	13.35M	6.61M	2.7M	1.81M
Cash Only	0	0	0	261K	32K	13.35M	1.1M	2.7M	1.81M
Short-Term Investments	0	0	0	0	0	0	5.51M	0	0
Accounts Receivable	74K	99K	34K	102K	73K	209K	222K	633K	933K
Days Sales Outstanding	12.55	18.14	5.61	51.92	39.53	49.18	39.57	56.5	39.2
Inventory	158K	93K	101K	113K	233K	291K	502K	1.32M	1.75M
Days Inventory Outstanding	25.45	18.4	21.7	48.3	88.13	68.84	102.25	129.59	107.6
Other Current Assets	0	0	0	0	0	0	109K	336K	577K
Total Non-Current Assets+	1M	695K	378K	1.38M	1.89M	3.06M	2.85M	4.9M	5.87M
Property, Plant & Equipment	831K	522K	200K	1.2M	1.36M	2.65M	2.46M	3.35M	3.84M
Fixed Asset Turnover	2.59x	3.82x	11.07x	0.60x	0.50x	0.59x	0.83x	1.22x	2.26x
Goodwill	0	0	0	0	311K	311K	311K	1.13M	1.13M
Intangible Assets	0	0	0	0	47K	33K	20K	326K	807K
Long-Term Investments	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	173K	173K	178K	178K	178K	63K	63K	95K	95K
Total Assets+	1.26M	894K	739K	1.89M	2.26M	16.98M	10.36M	9.96M	10.98M
Asset Turnover	1.71x	2.23x	2.99x	0.38x	0.30x	0.09x	0.20x	0.41x	0.79x
Asset Growth %	-	-0.29%	-0.17%	1.56%	0.19%	6.52%	-0.39%	-0.04%	0.1%
Total Current Liabilities+	384K	210K	407K	800K	1.33M	2.89M	859K	2.55M	2.47M
Accounts Payable	147K	63K	157K	510K	658K	254K	265K	1.23M	1.29M
Days Payables Outstanding	23.68	12.46	33.73	217.97	248.88	60.08	53.98	121.14	79.39
Short-Term Debt	0	0	0	0	216K	2.05M	15K	325K	97K
Deferred Revenue (Current)	0	0	0	0	38K	54K	0	20K	179K
Other Current Liabilities	66K	27K	142K	69K	170K	272K	316K	677K	606K
Current Ratio	0.67x	0.95x	0.89x	0.64x	0.27x	4.82x	8.74x	1.98x	2.07x
Quick Ratio	0.26x	0.50x	0.64x	0.50x	0.10x	4.72x	8.15x	1.46x	1.36x
Cash Conversion Cycle	14.32	24.07	-6.42	-117.75	-121.22	57.94	87.84	64.95	67.4
Total Non-Current Liabilities+	83K	59K	51K	710K	854K	2.01M	1.86M	2.24M	2.43M
Long-Term Debt	0	0	0	0	256K	266K	268K	513K	588K
Capital Lease Obligations	0	0	0	710K	598K	1.74M	1.59M	1.73M	1.84M
Deferred Tax Liabilities	16K	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	83K	59K	51K	0	0	0	0	0	0
Total Liabilities	467K	269K	458K	1.51M	2.19M	4.9M	2.72M	4.79M	4.9M
Total Debt+	0	0	0	917K	1.28M	4.26M	2.08M	2.8M	2.83M
Net Debt	0	0	0	656K	1.25M	-9.09M	982K	98K	1.02M
Debt / Equity	-	-	-	2.41x	17.99x	0.35x	0.27x	0.54x	0.46x
Debt / EBITDA	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-
Interest Coverage	-	-	-	-	-226.00x	-1.29x	-2.51x	-231.80x	-43.88x
Total Equity+	794K	625K	281K	380K	71K	12.09M	7.64M	5.17M	6.08M
Equity Growth %	-	-0.21%	-0.55%	0.35%	-0.81%	169.21%	-0.37%	-0.32%	0.18%
Book Value per Share	0.14	0.11	0.05	0.07	0.01	2.17	1.37	0.91	0.93
Total Shareholders' Equity	794K	625K	281K	380K	71K	12.09M	7.64M	4.7M	5.75M
Common Stock	794K	625K	281K	57K	99K	6K	6K	6K	8K
Retained Earnings	0	0	0	-238K	-2.5M	-6.81M	-11.56M	-14.71M	-18M
Treasury Stock	0	0	0	0	0	0	0	0	0
Accumulated OCI	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	469K	325K

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.32M	-777K	-1.54M	-1.81M	-1.8M	-2.75M	-2.99M	-3.24M	-3.87M
Operating CF Margin %	-0.61%	-0.39%	-0.7%	-2.53%	-2.67%	-1.77%	-1.46%	-0.79%	-0.45%
Operating CF Growth %	-	0.41%	-0.99%	-0.17%	0.01%	-0.53%	-0.09%	-0.08%	-0.19%
Net Income	-1.78M	-953K	-1.89M	-1.92M	-2.26M	-4.31M	-4.75M	-3.16M	-3.28M
Depreciation & Amortization	324K	316K	322K	67K	50K	113K	301K	443K	478K
Stock-Based Compensation	12K	7K	206K	4K	232K	285K	298K	217K	367K
Deferred Taxes	-63K	-16K	0	0	2K	-225K	0	0	0
Other Non-Cash Items	-9K	-8K	-14K	-1K	2K	1.98M	1.39M	-318K	-260K
Working Capital Changes	195K	-123K	36K	39K	177K	-593K	-234K	-421K	-1.17M
Change in Receivables	212K	-27K	66K	-68K	29K	-137K	-13K	-411K	-300K
Change in Inventory	46K	60K	-3K	-12K	-99K	-58K	-211K	-760K	-432K
Change in Payables	-35K	-84K	94K	203K	137K	-405K	11K	968K	182K
Cash from Investing+	0	-7K	0	0	-312K	-269K	-5.59M	4.46M	-775K
Capital Expenditures	0	-7K	0	0	-312K	-269K	-96K	-696K	-443K
CapEx % of Revenue	-	0%	-	-	0.46%	0.17%	0.05%	0.17%	0.05%
Acquisitions	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	-96K	-500K	0
Cash from Financing+	1.32M	784K	1.54M	2.08M	1.88M	16.34M	-3.66M	379K	3.75M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-
Other Financing	1.32M	784K	1.54M	1.34M	0	-115K	0	0	-241K
Net Change in Cash	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-1.32M	-784K	-1.54M	-1.81M	-2.11M	-3.02M	-3.09M	-3.93M	-4.31M
FCF Margin %	-0.61%	-0.39%	-0.7%	-2.53%	-3.14%	-1.95%	-1.51%	-0.96%	-0.5%
FCF Growth %	-	0.4%	-0.97%	-0.17%	-0.16%	-0.43%	-0.02%	-0.27%	-0.1%
FCF per Share	-0.24	-0.14	-0.28	-0.33	-0.38	-0.54	-0.55	-0.69	-0.66
FCF Conversion (FCF/Net Income)	0.74x	0.82x	0.82x	0.94x	0.80x	0.64x	0.63x	1.03x	1.18x
Interest Paid	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-223.68%	-134.32%	-416.78%	-581.85%	-1003.99%	-70.91%	-48.13%	-49.32%	-58.35%
Return on Invested Capital (ROIC)	-176.07%	-102.43%	-312.58%	-219.13%	-144.13%	-89.34%	-43.23%	-37.57%	-43.12%
Gross Margin	-5.3%	7.38%	23.23%	-19.11%	-43.18%	0.52%	12.5%	9.15%	31.63%
Net Margin	-82.53%	-47.84%	-85.31%	-268.2%	-335.9%	-277.89%	-231.74%	-77.21%	-37.76%
Debt / Equity	-	-	-	2.41x	17.99x	0.35x	0.27x	0.54x	0.46x
Interest Coverage	-	-	-	-	-226.00x	-1.29x	-2.51x	-231.80x	-43.88x
FCF Conversion	0.74x	0.82x	0.82x	0.94x	0.80x	0.64x	0.63x	1.03x	1.18x
Revenue Growth	-	-7.43%	11.09%	-67.6%	-6%	130.12%	32.04%	99.66%	112.47%

Revenue by Segment

	2023	2024
Contract Manufacturing	1.98M	1.98M
Contract Manufacturing Growth	-	-0.05%
Other Incomes	76K	243K
Other Incomes Growth	-	219.74%

Frequently Asked Questions

Growth & Financials

NEXGEL, Inc. (NXGL) reported $11.7M in revenue for fiscal year 2024. This represents a 442% increase from $2.2M in 2016.

NEXGEL, Inc. (NXGL) grew revenue by 112.5% over the past year. This is strong growth.

NEXGEL, Inc. (NXGL) reported a net loss of $2.9M for fiscal year 2024.

Dividend & Returns

NEXGEL, Inc. (NXGL) has a return on equity (ROE) of -58.3%. Negative ROE indicates the company is unprofitable.

NEXGEL, Inc. (NXGL) had negative free cash flow of $2.5M in fiscal year 2024, likely due to heavy capital investments.